90K (Mac-2 BP) and galectins in tumor progression and metastasis - Wikidata - wikimedia - TriplyDB

90K (Mac-2 BP) and galectins in tumor progression and metastasis

90K (Mac-2 BP) and galectins in tumor progression and metastasis

http://www.wikidata.org/entity/Q28242012

about

Galectin-3 and Beclin1/Atg6 genes in human cancers: using cDNA tissue panel, qRT-PCR, and logistic regression model to identify cancer cell biomarkers Mac-2 binding protein is a novel E-selectin ligand expressed by breast cancer cells Sialoglycoproteins and N-glycans from secreted exosomes of ovarian carcinoma cells Identification of novel tumor-associated cell surface sialoglycoproteins in human glioblastoma tumors using quantitative proteomics Quantitative glycoproteomics analysis reveals changes in N-glycosylation level associated with pancreatic ductal adenocarcinoma.Integrated analysis of global mRNA and protein expression data in HEK293 cells overexpressing PRL-1.Tumor biomarker glycoproteins in the seminal plasma of healthy human males are endogenous ligands for DC-SIGN.Carbohydrate recognition by boronolectins, small molecules, and lectins.Galectin-1 and its involvement in hepatocellular carcinoma aggressiveness Identification of Mac-2-binding protein as a putative marker of neuroendocrine tumors from the analysis of cell line secretomes.Galectin-1-binding glycoforms of haptoglobin with altered intracellular trafficking, and increase in metastatic breast cancer patients.The promigratory activity of the matricellular protein galectin-3 depends on the activation of PI-3 kinase.Investigation of galectin-3 function in the reproductive tract by identification of binding ligands in human seminal plasma Expression and significance of 90K/Mac-2BP in prostate cancer.Lectin galactoside-binding soluble 3 binding protein (LGALS3BP) is a tumor-associated immunomodulatory ligand for CD33-related Siglecs.Serum Fucosylated Haptoglobin as a Novel Diagnostic Biomarker for Predicting Hepatocyte Ballooning and Nonalcoholic Steatohepatitis.Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) recognizes a novel ligand, Mac-2-binding protein, characteristically expressed on human colorectal carcinomas Plasma clusterin as a candidate pre-diagnosis marker of colorectal cancer risk in the Florence cohort of the European Prospective Investigation into Cancer and Nutrition: a pilot study.Pancreatic satellite cells derived galectin-1 increase the progression and less survival of pancreatic ductal adenocarcinoma.The role of galectin-3 and galectin-3-binding protein in venous thrombosis.Co-purification of Mac-2 binding protein with galectin-3 and association with prostasomes in human semen Prognostic relevance of LGALS3BP in human colorectal carcinoma.Galectin-3 Binding Protein Secreted by Breast Cancer Cells Inhibits Monocyte-Derived Fibrocyte Differentiation.Evaluation of Fucosylated Haptoglobin and Mac-2 Binding Protein as Serum Biomarkers to Estimate Liver Fibrosis in Patients with Chronic Hepatitis C.Extracellular Vesicles from Ovarian Carcinoma Cells Display Specific Glycosignatures.Serum levels of cytoplasmic melanoma-associated antigen at diagnosis may predict clinical relapse in neuroblastoma patients Spectral library-based glycopeptide analysis-detection of circulating galectin-3 binding protein in pancreatic cancer.Immunohistochemical analysis of medullary breast carcinoma autoantigens in different histological types of breast carcinomas.Shoc2-tranduced ERK1/2 motility signals--Novel insights from functional genomics.Clinicopathological and prognostic significance of galectin-1 and vascular endothelial growth factor expression in gastric cancer Alteration of matrix metalloproteinase-3 O-glycan structure as a biomarker for disease activity of rheumatoid arthritis.Expression profiling of Galectin-3-depleted melanoma cells reveals its major role in melanoma cell plasticity and vasculogenic mimicry.90K Glycoprotein Promotes Degradation of Mutant β-Catenin Lacking the ISGylation or Phosphorylation Sites in the N-terminus.Biomarkers for malignant pleural mesothelioma: current status.Circulating autoantibodies to LGALS3BP: a novel biomarker for cancer.Inhibitory effect of modified citrus pectin on liver metastases in a mouse colon cancer model.A review of studies of the proteomes of circulating microparticles: key roles for galectin-3-binding protein-expressing microparticles in vascular diseases and systemic lupus erythematosus.Up-regulation of Mac-2 binding protein by hTERT in gastric cancer.LGALS3BP, lectin galactoside-binding soluble 3 binding protein, promotes oncogenic cellular events impeded by antibody intervention.Serum Mac-2 binding protein levels as a novel diagnostic biomarker for prediction of disease severity and nonalcoholic steatohepatitis.

P2860

Q21134996-6C566AA0-9433-45F0-ACE4-CB8FBAC9AF60 Q28274894-4F73B1D1-1CFA-418A-8ACF-2CC48BEAF7CC Q28535417-62530942-A3A9-4026-AD4D-26AF52CD9D47 Q28544645-E450A604-3DDC-4EA2-9952-1F6220B9C492 Q30576595-2891FDFE-5826-4715-8A0B-4336FB43AAAA Q30665898-88AD841C-A3AF-47E0-97D0-532465E72FB1 Q31031940-7798971C-7E32-4426-AD31-19BB6A72F768 Q33691290-E1260A21-1295-4BCE-B9C7-306D399EA83F Q33692511-F5A04E28-2C05-4DF2-8343-1EEB41F6895E Q33812900-A4EB71C1-7D9D-453E-9A74-5517DFB9D964 Q34058682-347754CC-1360-42DE-8DD8-DDA82BB49885 Q34117467-6235F51A-9F99-4D93-AB42-2C5C4734965F Q34268107-6AB84892-B442-4955-AB54-53D24A1E4B83 Q34515531-D53926BC-89FD-4201-948F-4AFF70A1E077 Q34580364-1BCF8BB3-91B2-48B8-BC33-EFD0112D2235 Q34785324-789C9DF3-4744-4C21-92E0-16636E6F7CD9 Q35063118-1902B0AD-B3FC-46A7-B12B-CD3E488C39A4 Q35101910-2F13E79A-B1A3-4033-BD33-1E2FF763F148 Q35111396-C11D976E-6029-487C-A55B-B8D3EBA6024D Q35171280-34D1A8E4-EC1A-41FA-B7D8-CA2F82B4D02D Q35534585-98D9F696-7D62-4079-ABBA-8CCEA348CD15 Q35899039-814AFEAA-6E89-4763-ABF3-0A6967746293 Q35931701-35AE29E4-ECA9-4895-8E8A-0E02A4C30023 Q35965881-4E85D539-F395-470B-8A78-6FE267716DAC Q36139088-C0E80541-70BE-4AE9-A5BD-F6D61F293EFA Q36184329-9EAE2FC2-4DB5-448B-A46A-0DA8818821E0 Q36408948-6185F423-D6D9-4018-B8C4-C97D60011ADC Q36497940-86ABFAE6-0C85-40D5-8EAD-4470256EB0CE Q36677993-C1A2AFA1-6E50-444D-80F7-0919B7E16B57 Q36759226-6A0840BB-06D4-4B55-A023-7031681E3F05 Q36923243-BCE7B043-8629-4DD3-911C-5D0576781F87 Q37061114-88CA51B3-F2DF-4E4D-A284-6BA56235D03F Q37284950-4467917C-737C-489D-8EC9-7CC94017F41E Q37335377-12A633C5-ECD8-4E74-A8AE-51DC191E30C2 Q37363290-0B094045-8FD8-4D70-822B-F3A5099CE6AF Q37423079-D63FBC3E-DDC8-48DE-98B6-8AC0A0CC4009 Q37742466-1BF77744-B657-4E1E-8A51-394AD9654C3C Q38307280-6CFB27B1-EA30-49A9-A3DF-73E8459005C7 Q39041034-520A140D-C715-40E4-AF27-CD82489AF393 Q39138238-C3D309C4-CC7D-4C5D-AB89-2ED197E32951

P2860

90K (Mac-2 BP) and galectins in tumor progression and metastasis

http://www.wikidata.org/entity/Q28242012

description

2004 nî lūn-bûn

@nan

2004 թուականին հրատարակուած գիտական յօդուած

@hyw

2004 թվականին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

90K (Mac-2 BP) and galectins in tumor progression and metastasis

@ast

90K (Mac-2 BP) and galectins in tumor progression and metastasis

@en

90K (Mac-2 BP) and galectins in tumor progression and metastasis

@nl

type

label

90K (Mac-2 BP) and galectins in tumor progression and metastasis

@ast

90K (Mac-2 BP) and galectins in tumor progression and metastasis

@en

90K (Mac-2 BP) and galectins in tumor progression and metastasis

@nl

prefLabel

90K (Mac-2 BP) and galectins in tumor progression and metastasis

@ast

90K (Mac-2 BP) and galectins in tumor progression and metastasis

@en

90K (Mac-2 BP) and galectins in tumor progression and metastasis

@nl

P1433

Q28242012-F6BE8089-87B3-4FB7-8DF6-852AE11AC12B

P1476

Q28242012-18B2D229-0185-4AE4-9820-6C857BA3DF07

P2093

Q28242012-17FCC386-FF2F-4D27-B359-00BBA7886205

Q28242012-450A42B6-5CC5-483A-863A-89516A48A8EA

Q28242012-5001C54B-5FC2-41D1-BC0F-1F3C9CEB31A9

Q28242012-589C73C1-7023-4A12-A4C7-9F5FF7A38203

Q28242012-67CBA4C6-41DC-44E6-B6DD-76E872DD0D00

Q28242012-6BE96E7E-BE4A-4B98-80FE-CCC9D74FB391

Q28242012-7DB1C87F-FFEE-4E39-856D-9852C720E7AB

Q28242012-DB843D04-EE77-4D64-A07C-767B915AA97B

Q28242012-F141A0F5-4C13-450A-A913-7FD561A2ED47

P2888

Q28242012-0898A472-24C2-401A-A7C0-A5290CF30989

P304

Q28242012-D300280E-404B-41EB-A81F-C4D5CB6FC218

P31

Q28242012-27947892-8CE3-4452-8E96-271073ABE22D

P3181

Q28242012-D2D5CD73-0345-48F9-90C1-1198EC4144EA

P356

Q28242012-3E9F5B9E-DD35-4415-B9FC-3F763C2B7CC1

P407

Q28242012-FFDD9A59-D8D2-4C14-83AF-DED9E1FE7F5C

P433

Q28242012-80D8689B-CDFA-47E0-8D56-F7C7D6191968

P478

Q28242012-14B426D2-B4F2-4943-967E-EF44EF127785

P50

Q28242012-B986C57A-0BBE-4858-9280-51E75C7324DF

P577

Q28242012-18228050-0754-45DA-9F26-0EA1D85C1B93

P6179

Q28242012-34F8A7F5-A769-4B69-948E-5B21BE57E618

P698

Q28242012-87AEEC44-B1CE-4F20-B6E8-51C548A5AA88

P3181

P356

B:GLYC.0000014085.00706.D4

P1433

Glycoconjugate Journal

P1476

90K (Mac-2 BP) and galectins in tumor progression and metastasis

@en

P2093

Alba Cumashi

http://www.w3.org/2001/XMLSchema#string

Antonino Grassadonia

http://www.w3.org/2001/XMLSchema#string

Enza Piccolo

http://www.w3.org/2001/XMLSchema#string

Ida Iurisci

http://www.w3.org/2001/XMLSchema#string

Maurizia D'Egidio

http://www.w3.org/2001/XMLSchema#string

Mauro Piantelli

http://www.w3.org/2001/XMLSchema#string

Nicola Tinari

http://www.w3.org/2001/XMLSchema#string

Pasquale Innominato

http://www.w3.org/2001/XMLSchema#string

Stefano Iacobelli

http://www.w3.org/2001/XMLSchema#string

P2888

b:glyc.0000014085.00706.d4

P304

551-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1451271

http://www.w3.org/2001/XMLSchema#string

P356

10.1023/B:GLYC.0000014085.00706.D4

http://www.w3.org/2001/XMLSchema#string

P407

P433

7-9

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1005565594

http://www.w3.org/2001/XMLSchema#string

P698

14758079

http://www.w3.org/2001/XMLSchema#string